The Global Research Awards for Nicotine Dependence (GRAND) 2009
Advancing the Understanding of the Mechanisms of Nicotine Dependence and Its Treatment
An Independent Competitive Grants Program Supported by Pfizer
Advancing the Understanding of the Mechanisms of Nicotine Dependence and Its Treatment
An Independent Competitive Grants Program Supported by Pfizer
Background
Pfizer is pleased to announce the 2009 funding of the Global Research Awards for Nicotine Dependence (GRAND), with a mission to:
Pfizer is pleased to announce the 2009 funding of the Global Research Awards for Nicotine Dependence (GRAND), with a mission to:
- Advance the understanding of the mechanisms of tobacco and nicotine dependence and its treatment.
Scope of the Program for 2009
- Human laboratory (eg, pharmacokinetics, pharmacodynamics, cravings, withdrawal)
- Pharmacotherapy of smoking cessation and relapse, and/or its interaction with behavioral support
- Characterization of subtypes of smokers and appropriate interventions.
Awards
It is anticipated that 6 awards will be granted in August 2009. These awards will have an upper limit of US$150,000 and are open to all researchers. Award recipients will be chosen by a board of international reviewers who are all recognized leaders in the field of nicotine dependence and smoking cessation.
Applications for 2009 now CLOSED
Links
An important goal of the GRAND
